Most recent posts

  • 11/07/17
    In 2015, 90 people died each day from an opioid overdose. If you subtract deaths attributed to heroin and synthetic opioids, such as illicitly manufactured fentanyl, the number drops to 42 deaths per day. That is still 42 deaths daily from drugs that were prescribed by a licensed health care professional. How did we get here?more...
  • 10/31/17
    I want to dispel a common myth: the myth that there is not enough data or enough of the right data to accomplish meaningful clinical improvement. The fact is we have enough data to reach the ultimate pursuit: reducing clinical variation and improving quality at the same time. The key is having the right amount of the right data. This means having data that is transparent, comes with the ability to drill down substantially and includes comparable benchmarks. A single source of truthmore...
  • 10/11/17
    The 2017 Atlantic hurricane season has been anything but merciful to the U.S. mainland and Puerto Rico with the recent devastation caused by Hurricanes Harvey, Irma and Maria. While we had warning they were coming, other natural disasters such as earthquakes, tornadoes and wildfires can strike with little or no warning. Obviously, we can’t avoid natural disasters completely, but hospital leaders and staff must prepare for them.more...
  • 09/27/17
    Sepsis is the most common, costly and deadly diagnosis in U.S. hospitals, with one sepsis patient being diagnosed every 20 seconds. More people die from sepsis than from prostate cancer, breast cancer and AIDS combined. Yet only a little more than half of American adults have even heard of sepsis. So what is it exactly? Sepsis is a body’s overwhelming and life-threatening response to infection. Severe sepsis is diagnosed when a patient has an infection plus additional signs of...more...
  • 09/19/17
    In a dynamic similar to the childhood game, hot potato, it seems that no side – payers, hospitals or suppliers – wants to be stuck alone at the end managing the high cost of care in the joint reconstruction market. Like kids playing the game, everyone is doing what they can to shift the hot potato of cost management elsewhere. In a webinar broadcast earlier this month, I shared what this game of hot potato looks like and other findings from the Vizient Technology Watch, Volume 2,...more...
  • 09/12/17
    Do you remember the first time that you ever saw a mirage? For most of us, it was the illusion of a sheet of water on blisteringly hot pavement as we gazed toward the horizon. Now we know that it was the product of refraction, of light bending in the heated air, but the first time we saw it we were sure there was a lake up ahead. From time to time, what may appear to be obvious is really our eyes playing tricks on us.more...
  • Sg2, a Vizient company
    09/07/17
    It’s no secret that doctors love data. We love it because it informs which devices we use, our treatment methodologies and how we can improve patient outcomes. And, while the move to value-based care has been a challenge for physicians, I believe the data that is being generated as a result offers an incredible opportunity to advance the quality of care as well as lower costs. A great example of this is the information captured in episodes of care.more...
  • 08/29/17
    Consider this statistic: In 2015, the amount of opioids prescribed was enough for every American to be medicated around the clock for three weeks. Say it aloud and your brain will have a hard time accepting what your mouth is telling it. The amount of opioids prescribed was enough for every single American to be medicated around the clock for three weeks.more...
  • 08/22/17
    If you look up the word “orphan” in the dictionary it is commonly used to convey loss and abandonment. However, when orphan is used in the pharmaceutical industry, it conveys dollar signs. Big dollar signs. The world’s 10 most expensive drugs are all classified as orphan drugs and the orphan drug market is expanding rapidly. Projected worldwide sales are expected to outpace conventional drugs by twofold over the next six years. Moreover, orphan drugs are projected to account...more...
  • 08/17/17
    Admit it. You thought I was going somewhere else with that, didn’t you? To be fair, the agency did say it disagreed “with commenters who suggested that CMS withdraw these models altogether …”more...